News

Monsanto insists merger won’t hurt innovation

The CEO of Monsanto insists that innovation won’t be hampered by merging with Bayer CropScience.

Right now, Rob Fraley says it takes nearly two decades to bring a new herbicide to market – first developing the chemistry, then the trait. But, Fraley says working in combination with Bayer, they could get a new product to market much faster with less money, “We can dramatically shorten that period and shave years off the development of products which would be great for farmers. And, it would be important for the company because it means that we can, you know, save some of that development time and invest in other innovations for growers.”

Rob Fraley told reporters that the merger will become an “innovation catalyst” for farmers around the world. The deal still needs regulatory approval.